--- title: "Profound Medical (TSE:PRN) Hits New 1-Year High - Time to Buy?" type: "News" locale: "en" url: "https://longbridge.com/en/news/272465052.md" description: "Profound Medical (TSE:PRN) reached a new 52-week high of C$12.40 during trading, closing at C$11.85. The company has a market cap of C$421 million, a P/E ratio of -8.79, and reported C$7.36 million in revenue with a negative EPS forecast of -1.90 for the fiscal year. Analysts currently rate the stock as a Hold, suggesting there may be better investment options available." datetime: "2026-01-13T22:17:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/272465052.md) - [en](https://longbridge.com/en/news/272465052.md) - [zh-HK](https://longbridge.com/zh-HK/news/272465052.md) --- # Profound Medical (TSE:PRN) Hits New 1-Year High - Time to Buy? Profound Medical Corp. (TSE:PRN - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$12.40 and last traded at C$11.85, with a volume of 11025 shares traded. The stock had previously closed at C$12.11. Get **Profound Medical** alerts: ## Profound Medical Stock Performance The company has a debt-to-equity ratio of 20.05, a quick ratio of 14.98 and a current ratio of 6.12. The company has a market capitalization of C$421.00 million, a P/E ratio of -8.79 and a beta of 1.19. The business has a 50 day moving average of C$9.67 and a 200-day moving average of C$8.15. Profound Medical (TSE:PRN - Get Free Report) last issued its earnings results on Thursday, November 13th. The company reported C$0.26 EPS for the quarter. Profound Medical had a negative return on equity of 85.22% and a negative net margin of 349.41%.The business had revenue of C$7.36 million during the quarter. On average, sell-side analysts predict that Profound Medical Corp. will post -1.9000001 EPS for the current fiscal year. ## Profound Medical Company Profile (Get Free Report) Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. ## Further Reading - Five stocks we like better than Profound Medical - Elon Taking SpaceX Public! $100 Pre-IPO Opportunity! - How a Family Trust May Be Able To Help Preserve Your Wealth - A U.S. “birthright” claim worth trillions - activated quietly - This stock gets a 94 out of 100 - First Time Since 2007: All Warnings Active _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Profound Medical Right Now? Before you consider Profound Medical, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Profound Medical wasn't on the list. While Profound Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [PROF.US](https://longbridge.com/en/quote/PROF.US.md) ## Related News & Research - [Profound Medical Showcases TULSA-PRO at Key Radiology Meeting](https://longbridge.com/en/news/281391648.md) - [Macquarie Is Pounding the Table on CoreWeave Stock with a New ‘Outperform’ Rating. Should You Buy Here?](https://longbridge.com/en/news/282888506.md) - [BofA says 3 contrarian indicators mean it might be a good time to jump into the market](https://longbridge.com/en/news/282714273.md) - [CoreWeave Just Scored a Major Anthropic Data Center Deal. Does That Make CRWV Stock a Buy Here?](https://longbridge.com/en/news/282736820.md) - [Fair Isaac Stock Is Down 40% This Year. Is Now the Time to Buy?](https://longbridge.com/en/news/282912529.md)